Julien Caldéraro

Active 2011–2025

Also published as
Julien Calderaro
100
Papers
19,292
Citations
58
h-index
92
i10-index

Citations

Citations per year for Julien Caldéraro1977: 1 citations1982: 1 citations1989: 1 citations1994: 2 citations1996: 1 citations1999: 1 citations2005: 2 citations2010: 1 citations2011: 1 citations2012: 13 citations2013: 64 citations2014: 101 citations2015: 121 citations2016: 175 citations2017: 207 citations2018: 180 citations2019: 566 citations2020: 1,119 citations2021: 1,371 citations2022: 1,137 citations2023: 947 citations2024: 1,465 citations2025: 866 citations2026: 51 citations1978–1981: no citations, so these years are not shown1983–1988: no citations, so these years are not shown1990–1993: no citations, so these years are not shown1995: no citations, so this year is not shown1997–1998: no citations, so these years are not shown2000–2004: no citations, so these years are not shown2006–2009: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 2,116 citing papers, 21.7% of this breakdownUnited States: 1,947 citing papers, 20% of this breakdownFrance: 622 citing papers, 6.4% of this breakdownGermany: 523 citing papers, 5.4% of this breakdownUnited Kingdom: 477 citing papers, 4.9% of this breakdownItaly: 467 citing papers, 4.8% of this breakdownJapan: 364 citing papers, 3.7% of this breakdownSpain: 294 citing papers, 3% of this breakdownSwitzerland: 215 citing papers, 2.2% of this breakdownSouth Korea: 215 citing papers, 2.2% of this breakdownNetherlands: 210 citing papers, 2.1% of this breakdownCanada: 189 citing papers, 1.9% of this breakdown
0%21.7%Other 21.7%

Fields

  • Medicine55.9%
  • Biochemistry, Genetics and Molecular Biology29.1%
  • Immunology and Microbiology7.7%
  • Computer Science4.9%
  • Engineering0.8%
  • Neuroscience0.3%
  • Other1.3%

Topics

  • Cancer Immunotherapy and Biomarkers7.8%
  • Hepatocellular Carcinoma Treatment and Prognosis6.1%
  • Immunotherapy and Immune Responses3.7%
  • Ferroptosis and cancer prognosis3%
  • Liver Disease Diagnosis and Treatment3%
  • Cancer Genomics and Diagnostics2.9%
  • Other73.5%

Coauthors

All papers

Open in search
  1. Tertiary lymphoid structures in the era of cancer immunotherapy

    Authors: , , , - Nature reviews. Cancer 2019 cited by 1,784

  2. B cells are associated with survival and immunotherapy response in sarcoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 1,970

  3. A deep learning model to predict RNA-Seq expression of tumours from whole slide images

    Authors: , , , , , , , , , , , , , - Nature Communications 2020 cited by 525

  4. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2015 cited by 1,852

  5. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma

    Authors: , , , , , , , , , , , , - Journal of Hepatology 2018 cited by 468

  6. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification

    Authors: , , , , , , , , , , , - Journal of Hepatology 2017 cited by 766

  7. Molecular and histological correlations in liver cancer

    Authors: , , , - Journal of Hepatology 2019 cited by 593

  8. Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma

    Authors: , , , - Journal of Hepatology 2022 cited by 344

  9. Predicting Survival After Hepatocellular Carcinoma Resection Using Deep Learning on Histological Slides

    Authors: , , , , , , , , , , , , , , , , , , - Hepatology 2020 cited by 311

  10. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , - Nature Genetics 2012 cited by 1,445

  11. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julien Calderaro, Stefano Caruso, Stefano Caruso, A. García, Stephen L. Chan, Stephen Lam Chan, Antonio D'Alessio, Alba Díaz, Antonia Digklia, Jean‐François Dufour, Jean-François Dufour, Narmin Ghaffari Laleh, Narmin Ghaffari Laleh, Purva Gopal, Rondell P. Graham, Alexandra Heurgué, Massimo Iavarone, Mercedes Iñarrairaegui, Jakob Nikolas Kather, Jakob Nikolas Kather, Ismaïl Labgaa, Sonia Lameiras, Patricia Legoix, Marie Lequoy, Howard H.W. Leung, Howard Ho-Wai Leung, Marco Maggioni, Marco Maggioni, Juan Ignacio Marín, Guillermo Mendoza-Pacas, Sophie Michalak, Beatriz Mínguez, Omar S. M. El Nahhas, Omar S M El Nahhas, Pooja Navale, Massih Ningarhari, Massih Ningarhari, Valérie Paradis, Jean–Michel Pawlotsky, Jean-Michel Pawlotsky, Riccardo Perbellini, Riccardo Perbellini, Simon Peter, David James Pinato, Pompilia Radu, Hélène Regnault, María Reig, Maria Reig, Mohamed Rela, Lorenza Rimassa, Margherita Rimini, María Teresa Salcedo, María Teresa Salcedo, Bruno Sangro, Christine Sempoux, Tung‐Hung Su, Callie Torres, Nguyen H. Tran, Eric Trépo, Marı́a Varela, Gontran Verset, Gontran Verset, Arndt Vogel, Dominique Wendum, Qinghe Zeng, Qinghe Zeng, Marianne Ziol, Léa Bruges, Viviane Gnemmi, Jean-Charles Nault and 23 more - The Lancet Oncology 2023 cited by 109

  12. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions

    Authors: , , , , , , , , , - Nature Communications 2013 cited by 662

  13. Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules

    Authors: , , , , , , , , , , , , , , , , - Clinical Cancer Research 2020 cited by 106

  14. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas

    Authors: , , , , , , , , , , , , , , , , - Nature Genetics 2015 cited by 480

  15. Artificial intelligence predicts immune and inflammatory gene signatures directly from hepatocellular carcinoma histology

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2022 cited by 112

  16. Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jérémy Augustin, Wei Qiang Leow, Howard H.W. Leung, Emmanuel Boleslawski, Mohamed Rela, Arnaud François, Anthony Wing-Hung, Alejandro Forner, María Reig, Manon Allaire, Olivier Scatton, Denis Chatelain, Camille Boulagnon‐Rombi, Nathalie Stürm, Benjamin Menahem, É. Frouin, David Tougeron, Christophe Tournigand, Emmanuelle Kempf, Haeryoung Kim, Massih Ningarhari, Sophie Michalak-Provost, Purva Gopal, Raffaele Brustia, Éric Vibert, Kornelius Schulze, Darius F. Rüther, Sören Weidemann, Rami Rhaiem, Jean–Michel Pawlotsky, Xuchen Zhang, Alain Luciani, Sebastien Mulé, Alexis Laurent, Giuliana Amaddeo, Hélène Regnault, Eléonora De Martin, Christine Sempoux, Pooja Navale, Maria Westerhoff, Regina Cheuk‐Lam Lo, Jan Bednarsch, Annette Gouw, Catherine Guettier, Marie Lequoy, Kenichi Harada, Pimsiri Sripongpun, Poowadon Wetwittayaklang, Nicolas Loménie, Jarukit Tantipisit, Apichat Kaewdech, Jeanne Shen, Valérie Paradis, Stefano Caruso, Jakob Nikolas Kather - Nature Communications 2023 cited by 77

  17. Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma

    Authors: , , , , , , , , , , , - Gut 2021 cited by 228

  18. Combined hepatocellular-cholangiocarcinoma: An update

    Authors: , , - Journal of Hepatology 2021 cited by 194

  19. Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features

    Authors: , , , , , , , , , , , - Hepatology 2016 cited by 440

  20. APC germline hepatoblastomas demonstrate cisplatin-induced intratumor tertiary lymphoid structures

    Authors: , , , , , , , , , , , , , , , , , - OncoImmunology 2019 cited by 75

  21. Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progression

    Authors: , , , , , , , , , , , - Hepatology 2016 cited by 311

  22. Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2019 cited by 212

  23. Artificial intelligence-based pathology for gastrointestinal and hepatobiliary cancers

    Authors: , - Gut 2020 cited by 97

  24. Artificial intelligence in liver cancer — new tools for research and patient management

    Authors: , , , , - Nature Reviews Gastroenterology & Hepatology 2024 cited by 58